.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chinese Patent Office
Farmers Insurance
Dow
Healthtrust
Harvard Business School
AstraZeneca
Covington
Deloitte
Cerilliant

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019243

« Back to Dashboard

NDA 019243 describes PROVENTIL, which is a drug marketed by Schering and 3m Drug Delivery and is included in six NDAs. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the PROVENTIL profile page.

The generic ingredient in PROVENTIL is albuterol sulfate. There are thirty-seven drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

Summary for 019243

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrengthEQ 0.5% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 14, 1987TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrengthEQ 0.083% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 14, 1987TE:RLD:No

Expired Orange Book Patents for NDA: 019243

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
ScheringPROVENTILalbuterol sulfateSOLUTION;INHALATION019243-002Jan 14, 1987► Subscribe► Subscribe
ScheringPROVENTILalbuterol sulfateSOLUTION;INHALATION019243-001Jan 14, 1987► Subscribe► Subscribe
ScheringPROVENTILalbuterol sulfateSOLUTION;INHALATION019243-001Jan 14, 1987► Subscribe► Subscribe
ScheringPROVENTILalbuterol sulfateSOLUTION;INHALATION019243-002Jan 14, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Chinese Patent Office
Novartis
Dow
Cipla
Healthtrust
Fuji
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot